For clinicians, we hope these findings may prompt a more thoughtful, individualized approach when considering these therapies in higher-risk patients who have both obesity and autoimmune disease. I am excited about the combination of medications for these diseases pairing medicines with known benefits to treat the autoimmune disease with a GLP-1RA, said Sheer
Peptides: CJC-1295 (No DAC) + Ipamorelin
But not everyones on board
SkinnyRx presents a telehealth-based platform designed to connect eligible patients with licensed providers who may prescribe GLP-1 medications such as semaglutide and tirzepatide, depending on individual clinical evaluation
Mol Neurodegeneration 16 , 71 (2021)
Coupled with expert insights, scientific dialogue, and firsthand experience with this innovation in diabetes care